Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury
Ended Project Grant Awarded Last action
- Award ID
- R43AI155197
- Recipient
-
Ossium Health, Inc. UEI FFNHJ2RDRHW3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,998
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Indiana, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,998 |
Quick answers
Who received award R43AI155197?
R43AI155197 was awarded to Ossium Health, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 18, 2020.
How much is award R43AI155197 worth?
$299,998 has been obligated on R43AI155197.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award